alovudine has been researched along with Cerebral Infarction, Middle Cerebral Artery in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ardaya, M; Cavaliere, F; Cossío, U; Domercq, M; Garbizu, M; Gómez-Vallejo, V; Gutiérrez, JJ; Higuchi, M; Joya, A; Llop, J; Martín, A; Matute, C; Montilla, A; Padro, D; Plaza-García, S; Pulagam, KR; Ramos-Cabrer, P; Rios, X | 1 |
| Backes, H; Fink, GR; Graf, R; Hoehn, M; Jantzen, SU; Muesken, S; Neumaier, B; Rueger, MA; Schnakenburg, K; Schroeter, M; Walberer, M | 1 |
2 other study(ies) available for alovudine and Cerebral Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
Topics: Adenosine A1 Receptor Antagonists; Animals; Brain; Dideoxynucleosides; Immunohistochemistry; Infarction, Middle Cerebral Artery; Inflammation; Leukocytes; Macrophage Activation; Magnetic Resonance Imaging; Microglia; Multimodal Imaging; Positron-Emission Tomography; Pyrazoles; Pyrimidines; Radiopharmaceuticals; Rats; Receptor, Adenosine A1; Xanthines | 2021 |
Effects of minocycline on endogenous neural stem cells after experimental stroke.
Topics: 2',3'-Cyclic-Nucleotide Phosphodiesterases; Animals; Anti-Bacterial Agents; Brain Infarction; Brain Mapping; Bromodeoxyuridine; Carbon Isotopes; CD11b Antigen; Cell Differentiation; Cell Proliferation; Cell Survival; Dideoxynucleosides; Disease Models, Animal; Dose-Response Relationship, Drug; Embryo, Mammalian; Encephalitis; Glial Fibrillary Acidic Protein; Infarction, Middle Cerebral Artery; Intermediate Filament Proteins; Isoquinolines; Magnetic Resonance Imaging; Male; Minocycline; Nerve Tissue Proteins; Nestin; Neural Stem Cells; Positron-Emission Tomography; Rats; Rats, Wistar; Time Factors; Tubulin | 2012 |